H.R. 9988 · 119th Congress · Health
FASTER Act of 2026
- IntroducedJul 30, 2026 Done
- CommitteeReferred to Energy and Commerce Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Full text
No CRS summary yet · 399 wordsH.R. 9988 · Introduced in House · Jul 30, 2026
This Act may be cited as the Food Allergy Safety, Treatment, Education, and Research Act of 2026 or the FASTER Act of 2026 .
(a) In general. Section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ) is amended— (1) in subsection (qq)(1), by striking wheat and inserting gluten-containing grain ; and (2) by adding at the end the following: (tt) The term gluten-containing grain means one of the following grains, or a crossbred hybrid of such grains, such as triticale: (1) Wheat, including any species in the genus Triticum. (2) Rye, including any species in the genus Secale. (3) Barley, including any species in the genus Hordeum. (4) Oats, including any species in the genus Avena sativa. .
(b) Revision of Manual of Compliance Policy Guides. Not later than 1 year after the date of enactment of this Act, the Administrator of Food and Drugs shall revise each section related to major food allergens (as defined in section 201(qq) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(qq) )) in the Manual of Compliance Policy Guides issued by the Food and Drug Administration for purposes of implementing the amendments made by this section.
(c) Applicability. The amendments made by this section shall apply to any food that is introduced or delivered for introduction into interstate commerce on or after the date that is 1 year after the date of enactment of this Act.
Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on— (1) surveillance of and collection of data on— (A) the prevalence of Celiac disease in the United States; and (B) the severity of any allergic reaction with respect to a specific food or food ingredient in an individual with Celiac disease; (2) any gap in such surveillance or collection of data; (3) development of effective diagnostics for Celiac disease; (4) any method for preventing the onset of Celiac disease; (5) any method for reducing any risk related to living with Celiac disease; and (6) development of new therapeutics to prevent, treat, cure, or manage Celiac disease.
Shown here because the text is under 500 words. Open on Congress.gov
Who lobbies on it
No lobbying filing on file names H.R. 9988.
Organizations that named H.R. 9988 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Jul 30, 2026Referred to the House Committee on Energy and Commerce.
- Jul 30, 2026Introduced in House